Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,641,287)	$ (3,488,659)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	103,700	100,792
Loss on issuance of preferred shares for accounts payable- related party	0	142,669
Common shares issued as compensation and for services	80,250	76,500
Warrants granted to Scientific Advisory Board	3,201	1,441
Depreciation	348,096
Amortization of loan origination fees	18,013	1,638
Amortization	4,135	4,135
Change in fair value of derivative liabilities	0	(274,449)
Loss on disposal of property and equipment	2,026	0
Write-off of deferred financing costs	12,190	0
Changes in operating assets and liabilities:
Prepaid expenses	182,765	12,382
Other assets	7,820	7,820
Accounts payable	(195,585)	362,464
Accounts payable - related party	(432,676)	163,587
Accrued expenses	(43,978)	(16,239)
NET CASH USED IN OPERATING ACTIVITIES	(4,551,330)	(2,560,245)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(43,565)	(4,139)
NET CASH USED IN FINANCING ACTIVITIES	(43,565)	(4,139)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock and warrants	10,442,216	0
Proceeds from note payable -related party	0	1,100,000
Payment of note payable - related party	(1,100,000)	0
Deferred financing costs	0	(383,175)
Payment of loan payable	(62,843)	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	9,279,373	716,825
NET CHANGE IN CASH AND CASH EQUIVALENTS	4,684,478	(1,847,559)
Cash and cash equivalents at beginning of period	13,708,594	2,555,207
Cash and cash equivalents at end of period	18,393,072	707,648
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	655	0
Non-cash Financing and Investing Activities:
Series A preferred stock issued for accounts payable-related party	0	250,000
Series A preferred stock issued for loan origination fee	$ 0	$ 39,301